CBIH Commences Clinical Trials of Osteoarthritis Injection “Orthocann”

 CBIH Commences Clinical Trials of Osteoarthritis Injection “Orthocann”

(marketscreener.com) Cannabis Bioscience International Holdings, Inc. has announced the enrollment of the first patient for the clinical trial of its new intra-articular cannabinoid-based injection for knee osteoarthritis. The company plans to test the produc…

Houston, Texas–(Newsfile Corp. – March 20, 2024) – Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH) has announced the enrollment of the first patient for the clinical trial of its n…